Overview

Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is determine if the combination of zonisamide SR and bupropion SR are is more effective than either drug given alone or placebo in the treatment of obesity.
Phase:
Phase 2
Details
Lead Sponsor:
Orexigen Therapeutics, Inc
Treatments:
Bupropion
Zonisamide